Literature DB >> 20621346

Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition.

Asuka Hamasaka, Naoya Yoshioka, Riichiro Abe, Satoshi Kishino, Kazuo Umezawa, Michitaka Ozaki, Satoru Todo, Hiroshi Shimizu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20621346     DOI： 10.1016/j.jaci.2010.05.020

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

1.  Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone.

Authors:  Masatoshi Takeiri; Miyuki Tachibana; Ayumi Kaneda; Ayumi Ito; Yuichi Ishikawa; Shigeru Nishiyama; Ryoichi Goto; Kenichiro Yamashita; Susumu Shibasaki; Gentaro Hirokata; Michitaka Ozaki; Satoru Todo; Kazuo Umezawa
Journal:  Inflamm Res       Date:  2011-05-28       Impact factor: 4.575

Review 2.  Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.

Authors:  Yinzhi Lin; Tamami Ukaji; Naoki Koide; Kazuo Umezawa
Journal:  Int J Mol Sci       Date:  2018-03-03       Impact factor: 5.923

3.  Combination Effect of Titrated Extract of Centella asiatica and Astaxanthin in a Mouse Model of Phthalic Anhydride-Induced Atopic Dermatitis.

Authors:  Ju Ho Park; In Jun Yeo; Jun Sung Jang; Ki Cheon Kim; Mi Hee Park; Hee Pom Lee; Sang Bae Han; Jin Tae Hong
Journal:  Allergy Asthma Immunol Res       Date:  2019-07       Impact factor: 5.764
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.